Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Companies

Roche Diagnostics Sees Data Sourcing, AI and Partnerships As Paving The Way to Personalized Health Care, But Challenges Remain

Two Roche Diagnostics executives outlined the company's vision toward personalized health care. Machine learning, partnerships and data sourcing are key. 

Personalized Medicine Business Strategies Digital Health

Latest From Companies

Execs On The Move: Operating And Science Appointments At Accelerate And BioTelemetry; Leadership Change At Revenio

In vitro testing company Accelerate Diagnostics fills COO slot; remote medical technology firm BioTelemetry appoints a CMO; a new chief executive is in place at medical measuring instruments-maker Revenio Group; and more.

Appointments Commercial

Boston Scientific Closes Multibillion-Dollar BTG Deal

Boston Scientific has completed the acquisition of UK interventional medicine specialist BTG. The deal, which was announced in November last year is Boston Scientific’s biggest since its controversial 2006 acquisition of heart device maker Guidant Corp. for $27bn.

M & A Deals

QUOTED. 19 August 2019. Michael Carrel.

AtriCure Inc. has closed a $300m structured deal to acquire SentreHEART Inc., the privately held developer of the Lariat percutaneous left atrial appendage (LAA) closure device. See what AtriCure CEO Michael Carrel said about it here.

Quoted Deals

AtriCure Adds Lariat LAA Closure System With $300M SentreHeart Acquisition

AtriCure Inc. has closed a $300m structured deal to acquire SentreHEART Inc., a privately held developer of percutaneous left atrial appendage management solutions.

Cardiovascular M & A

Siemens Snaps Up Corindus Vascular Robotics For $1.1Bn

Siemens Healthineers AG has signed a billion-dollar deal to merge with US firm Corindus Vascular Robotics, expanding the German company's advanced therapies business.

M & A Deals

Australia Clears Nexstim Neuromodulation Depression Treatment

Neuromodulation firm Nexstim has received regulatory clearance for its SmartFocus TMS system for treating major depressive disorder (MDD) in Australia.

Australia Approvals

New Heartache For Abbott Implantable Cardiac Devices After Manufacturing Flaw Discovered

US regulators have notified the public about a recall of certain Abbott Ellipse implantable cardioverter defibrillators that are prone to electrical shorting due a manufacturing flaw. While the number of devices so far in the US is very small, the recall highlights continued issues with the ICDs since Abbott acquired them from St. Jude almost three years ago.

Regulation Safety

QUOTED. 2 August 2019. Bryan Hanson.

Zimmer Biomet says its long-term plan to return to steady growth is ahead of schedule. See what company CEO Bryan Hanson said about it here.

Quoted Sales & Earnings

Zimmer Biomet Continues Turnaround Lead by ROSA Robot

Zimmer Biomet’s net sales were up 1.2% year-over-year in the second quarter. CEO Bryan Hanson said the ROSA Knee robotic surgery system is performing even better than expected since it launched earlier this year, and is expected to be an important revenue-driver in the future.

Sales & Earnings Orthopedics
See All